Logo
x

Search

Subscribe Now

Collaborate

Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSCLC

Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSC...

  • October 14, 2021
Nestle and Seres Collaborate to Jointly Commercialize SER-109 for Recurrent Clostridioides difficile Infection

Nestle and Seres Collaborate to Jointly Commercialize SER-109 for Recurrent Clostridioides difficile Infection

  • July 2, 2021
BridgeBio Collaborates with Helsinn to Co- Develop and Commercialize Infigratinib in Oncology

BridgeBio Collaborates with Helsinn to Co- Develop and Commercialize Infigratinib in Oncology

  • April 1, 2021
Samsung Bioepis and Yuhan Collaborate for the Commercialization of Adalloce (biosimilar- adalimumab) in Korea

Samsung Bioepis and Yuhan Collaborate for the Commercialization of Adalloce (biosimilar- adalimumab) in Korea

  • March 15, 2021
UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

  • February 25, 2021
Novartis Collaborates with Bill & Melinda Gates Foundation to Discover and Develop Gene Therapy for Sickle Cell Disease

Novartis Collaborates with Bill & Melinda Gates Foundation to Discover and Develop Gene Therapy for Sickle Cell Disease

  • February 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.